Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : AqubotulinumtoxinA
Therapeutic Area : Dermatology
Study Phase : IND Enabling
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : Dermatox (botulinum Toxin Type A-aqu) is a neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. It is being investigated for the improvement of skin quality and reduction of fine lines for face and nec...
Brand Name : Dermatox
Molecule Type : Large molecule
Upfront Cash : Not Applicable
April 28, 2023
Lead Product(s) : AqubotulinumtoxinA
Therapeutic Area : Dermatology
Highest Development Status : IND Enabling
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Dermatology
Study Phase : IND Enabling
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Aquavit Files Two IND's For Its Botulinum Toxin With FDA
Details : DTX-023 (botulinum toxin type A) is a neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum. It is being investigated for primary axillary hyperhidrosis and palmar hyperhidrosis.
Brand Name : DTX-023
Molecule Type : Large molecule
Upfront Cash : Not Applicable
March 17, 2023
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Dermatology
Highest Development Status : IND Enabling
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Dermatology
Study Phase : IND Enabling
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Aquavit Files IND with FDA for DTX-021, a New Botulinum Toxin
Details : Dermatox (DTX-021) is a botulinum toxin type A drug, highly purified and clinically tested injectable neuromodulator with a 900 kDa protein complex derived from neurotoxins produced by Clostridium botulinum.
Brand Name : Dermatox
Molecule Type : Large molecule
Upfront Cash : Not Applicable
March 24, 2022
Lead Product(s) : Botulinum toxin type A
Therapeutic Area : Dermatology
Highest Development Status : IND Enabling
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : AQV-1122
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Aquavit's AQV-1122 COVID-19 Vaccine Patent Approval Fast Tracked by USPTO
Details : Aquavit received a notice of allowance through the USPTO's Fast-Track Prioritized Examination Pilot Program (PEPP) for the application of the company's proprietary technology for self-injectable Covid 19 vaccination (AQV-1122).
Brand Name : AQV-1122
Molecule Type : Vaccine
Upfront Cash : Not Applicable
September 01, 2021
Lead Product(s) : AQV-1122
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
LOOKING FOR A SUPPLIER?